 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
  |
|
Jubilant Life Sciences Limited, an integrated
pharmaceutical and life sciences company, is the largest Custom
Research and Manufacturing Services (CRAMS) player and a leading Drug
Discovery and Development Solution (DDDS) provider out of India.
Recently it has been ranked No. 6 amongst the Top 10 global contract
manufacturing & services outsourcing players of the pharmaceutical
industry (Source: UNCTAD).
Over the years, we have extended our footprint beyond India in the USA, Canada, Europe, and other countries across the globe. We have expanded our business by building capabilities internally, through strategic build outs and acquisitions, resulting in a network of 7 world class manufacturing facilities in India and 3 in North America and a team of ~5800 people across the globe with 1450 in North America, with international sales in more than 75 countries. We offer, Life Sciences Products
Our multi-location presence helps us get closer to our customers and serve them better with the best in class products developed most efficiently, economically and on time. At Jubilant we are engaged in continuous improvement of our products and processes to enhance the quality of our production and cost competitiveness in order to build value for our customers. We serve our customers across the globe in over 60 countries and have strong relationships with 19 of the Top 20 Pharma companies, and 7 out of the top 10 Agrochemical companies world-wide. Drug Discovery and Development Services The Drug Discovery and Development Services (DDDS) group is integrated across therapeutic areas of oncology, Metabolic Diseases, Central Nervous System (CNS) and Infectious Diseases. It collaborates with global pharmaceutical companies, biotech, and academia for lead generation, preclinical & clinical drug development across various target and technology disease platforms. The Drug Discovery and Development Services (DDDS) group within Jubilant constitutes 3 of its subsidiaries. Jubilant Biosys, Jubilant Chemsys and Jubilant Clinsys. With over 1000 highly skilled and experienced scientific and medical personnel spread across Bengaluru and Noida in India, Europe and the US, the DDDS group leverages the capabilities in emerging markets for a global outcome, accelerating the global drug development efforts. Jubilant's talent pool is a blend of PhDs, MDs and Masters, across various disciplines, and brings a wide range of experience from global pharmaceutical companies, biotech and academia. State-of-the-art infrastructure and enabling technologies further augment Jubilant’s philosophy of creative partnering and provides all collaborators optimal outcome in managing their functional and portfolio needs. The state-of –the-art technology platforms span across in Silico Modelling, Protein Crystallography, High Throughput Screening and profiling technologies including in vivo screening technologies and parallel synthesis in the discovery area; and also extends to EDC platforms in Clinical development. Jubilant also partners with technology companies across the word in enabling cutting edge discovery and development efforts. Jubilant's progress in diverse businesses has been made possible through the contribution of R&D for quality, non-infringing process for product development and cost reduction through process innovation. Innovation at Jubilant is backed by strong chemistry and bio science expertise and the knowledge bank created by the Company over the years. The Company has harnessed its strengths – a strong R&D team, modern R&D facilities, command over cheap technologies and economies of scale into a synergistic organic entity, continuously creating and nurturing high quality products and technologies. In line with our continued focus on sustainability of our business we aim at improving stakeholder value through improved eco efficient use of capital and natural resources. Our approach to sustainable development focuses on the triple bottom line of Economics, Environment and Social performance. The company is committed and working on various areas for energy conservation and climate change mitigation. Our Sustainability efforts have been reported through a Sustainability report since 2003 and our report has been rated A+ since 2007 by Global Reporting Initiative (GRI). This reflects our commitment towards sustainable development and continued efforts directed towards protecting the environment wherever we operate. Corporate Social Responsibility is an integral part of how we conduct our business and our efforts are directed towards community development through focus on primary education, basic Healthcare Service, and Livelihood generation programs focused on improving the employability of women and local youth. We have been recognized with several awards which bear testimony to our commitment towards operational excellence, innovation, corporate governance and social responsibility. Some of the recent awards are:
We are committed to leverage innovation and our scale of operations at every step of the pharma value chain to deliver value to our stakeholders. We are Jubilant Life Sciences Ltd. |
 |
|
Home | about Us | Businesses | Innovation | Investors | Sustainability | Media Center | Careers | Contact Us |
|
| Site Map | Privacy Policy | Disclaimer |
© Copyright Jubilant Life Sciences. All rights
reserved. |
This site is best viewed in 800 x 600 and above, IE 5.0+ |
